Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
Journal: The New England journal of medicine
Published: July 08, 2026
Quality of life improvements with setmelanotide treatment in acquired hypothalamic obesity: TRANSCEND trial interview results from US participants.
Journal: Frontiers in behavioral neuroscience
Published: March 13, 2026
Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.
Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.
Journal: Diabetes, obesity & metabolism
Published: January 21, 2026
Current and Future Pharmacological Interventions for Acquired Hypothalamic Obesity.
Journal: Drugs
Published: September 30, 2025
A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.
Journal: Metabolism: clinical and experimental
Published: August 05, 2025
Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response.
Journal: Reviews in endocrine & metabolic disorders
Published: June 17, 2025
Correction to: Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: a Roundtable Summary.
Journal: Current obesity reports
Published: February 21, 2025
The Impact of Eating Behaviors on Ultraprocessed Food Consumption Over 12 Months in Children.
Journal: Obesity (Silver Spring, Md.)
Published: February 07, 2025
The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats.
Journal: International journal of molecular sciences
Published: February 01, 2025
The Chimeric Peptide (GEP44) Reduces Body Weight and Both Energy Intake and Energy Expenditure in Diet-Induced Obese Rats.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025
Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: A Roundtable Summary.
Journal: Current obesity reports
Published: December 11, 2024
Setmelanotide for the treatment of severe early-childhood genetic obesity.
Journal: The lancet. Diabetes & endocrinology
Published: October 01, 2024
Last Updated: 09/26/2026